SLC27A2 and diabetic kidney disease: The key evidence shows that the absence of FATP2 can significantly reverse the renal pathological changes, functional abnormalities, and hyperglycemia in DKD model mice, confirming that FATP2 is a key molecular target for the occurrence of DKD [79].